NCT00507637View on ClinicalTrials.gov

Blepharospasm Short Interval

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Blepharospasm
Interventions
DRUG

NT 201

Injection of up to 50 Units NT 201 (incobotulinumtoxinA/Xeomin®) per eye and injection visit (8 injections visits in total).

Trial Locations (1)

53125

Universitaets Augenklinik, Bonn

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00507637 - Blepharospasm Short Interval | Biotech Hunter | Biotech Hunter